These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11209234)

  • 1. [Photo-hemo-correction in the complex treatment of patients with obliterating atherosclerosis of the arteries of the lower limbs].
    Leont'eva NV; Belotserkovskiĭ MV; Rostova NS; Zolotnitskaia VP; Leont'ev SA; Dmitrieva IaV; Dmitrieva LA
    Vestn Khir Im I I Grek; 2000; 159(6):57-60. PubMed ID: 11209234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravascular laser irradiation of blood in multimodal treatment of patients with obliterating diseases of the lower limb vessels].
    Losev RZ; Tsarev OA; Gur'ianov AM
    Grud Serdechnososudistaia Khir; 1992; (1-2):34-7. PubMed ID: 1586517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of vazaprostan in the treatment of multifocal peripheral obliterating lesions of arteries of the lower limbs].
    Driuk NF; Mishalov VG; Pavlichenko LN
    Klin Khir (1962); 1994; (10):26-8. PubMed ID: 7602901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of intravascular laser irradiation of blood in complex preoperative care of patients with arterial occlusive diseases of the lower limbs].
    Homon ML
    Klin Khir; 1997; (9-10):25-6. PubMed ID: 9511319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II; Guch AA
    Klin Khir (1962); 1994; (7):22-4. PubMed ID: 7823491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of a new pentoxifilline form-vasonit retard in the treatment of patients with obliterating diseases of the lower limbs arteries].
    Koshkin VM
    Ter Arkh; 2005; 77(4):83-4. PubMed ID: 15938541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Parakhoniak NV; Zubova TA
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lasers in the treatment of arterial occlusive diseases of the limbs].
    Shabanov AN; Dmitriev AE; Gol'ts MV; Tatevosian AS; Klivev AV
    Vestn Khir Im I I Grek; 1976 Dec; 117(12):53-7. PubMed ID: 1034994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional methods of assessment of the blood flow in the lower limbs of the patients with obliterating atherosclerosis during complex conservative treatment].
    Esipov AV; Kotenko KV; Iamenskov VV
    Voen Med Zh; 2015 Jan; 336(1):41-4. PubMed ID: 25916036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous laser irradiation of the blood in occlusive vascular diseases of the extremities].
    Shval'b PG; Zakharchenko AIa; Sigaev AA; Kataev MI
    Sov Med; 1990; (3):21-3. PubMed ID: 2367895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelet therapy in patients with chronic obliterating diseases of lower-limb arteries].
    Kuznetsov MR; Tepliakov SA; Sizarev AV; Tugdumov BV; Dzhalilova NS
    Angiol Sosud Khir; 2010; 16(1):43-7. PubMed ID: 20635715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endovascular dilatation in the treatment of patients with obliterating atherosclerosis of main arteries of lower extremities].
    Efimenko NA; Kokhan EP; Ivanov VA; Gilevskiĭ SG
    Voen Med Zh; 2002 Feb; 323(2):18-22. PubMed ID: 11901692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of dimephosphon in patients with obliterating diseases of the vessels of lower limbs during the postoperative period].
    Malenkova TS; Neĭmark MI; Sidorenkova NB
    Anesteziol Reanimatol; 1994; (3):47-50. PubMed ID: 8080130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of arteriosclerosis obliterans of the lower extremities].
    Malinovskiĭ NN; Reshetnikov EA; Kobtseva LF; Popova NE
    Khirurgiia (Mosk); 1991 Jan; (1):6-9. PubMed ID: 2041318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological correction of disorders of antithrombogenic properties of the vascular wall in patients with arteriosclerosis of the lower extremities].
    Adamchik AS; Kokhan EP; Grishin GP
    Klin Khir (1962); 1991; (7):32-5. PubMed ID: 1942829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of ticlopidine and nifedipine on platelet aggregation in patients with obliterating arteriopathy of the lower limbs].
    Hevia Alonso A; Gago Angelino J; López-Valpuesta FJ; Serrano Molina JS; Fernández-Sanz S
    Rev Clin Esp; 1992 Apr; 190(6):295-8. PubMed ID: 1598427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.